CRISPR Therapeutics AG (CRSP) Gained 14.64% or 5.46 To Price $42.7 On Friday


CRISPR Therapeutics AG (CRSP) gained 14.64% or 5.46 to $42.7. It is approximately 1.50 million shares traded, which is 331.42% compare to the average total volume 453126. The market cap of CRSP is $2.26 billion. The year to date change is 39.35%. The 52 week price range is from $22.22 to $70.09. Price of CRSP have changed 4.72% during last week. It have changed -11.50% over last month, -2.97% over last 3 months, 3.70% over last 6 months and -45.09% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for CRSP is 38.11. It is -10.75% below current price. The 200-day Moving Averages for CRSP is 37.99. It is -11.03% below current price. The 52-week High is 70.09. It is 64.15% from the current price. The 52-week Low is 22.22. It is -47.96% from current price.

There are some statistics of CRSP. It is has market cap $2.26 billion. The share outstanding is 52.91 million. The average volume is 453126. The percent of top 15 Institution holding is 56.50%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of CRSP is -55.24%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of CRSP is -42.44%.


Tags:

Share this post